Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ApoE Mounts A Comeback In Alzheimer’s

Jan 22 2016

• By Mark Ratner

Related Content

Alzheimer’s R&D In Brief: Roche’s Crenezumab Misses Endpoints, Novartis Plans Large New Genetic Study

Jul 21 2014

Discredited SIRT1 Stops DNA Damage In Neurons

Jul 26 2013

Related Companies

Buck Institute for Research on Aging

University of California, Los Angeles

Allon Therapeutics, Inc.

Paladin Pharma Inc.

Novartis AG

Additional Topics

BioPharmaceutical

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window